Skip to main content
Premium Trial:

Request an Annual Quote

Grail: Harpal Kumar

Grail has appointed Harpal Kumar as president of Grail Europe, a new role within the company. Kumar joins Grail from Johnson & Johnson where he most recently served as senior vice president and head of innovation EMEA, overseeing a portfolio of regional co-investments and collaborations. Before joining Johnson & Johnson, Kumar spent 15 years with Cancer Research UK, serving as the organization's CEO from April 2007 until June 2018. Prior to this, he was CRUK's COO and executive director of development, as well as chief executive of CRUK subsidiary Cancer Research Technology.

Before CRUK, he worked with McKinsey & Co, the Papworth Trust, and Nexan Group. He received a master's degree in chemical engineering from the University of Cambridge, and an MBA from Harvard Business School. He has been awarded honorary doctorates from the Universities of Manchester, Newcastle, and Glasgow, and the Institute of Cancer Research, and he is a Fellow of the Academy of Medical Sciences. In 2016, he was knighted by Her Majesty Queen Elizabeth II for services to cancer research.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.